neobookRx

Myocardial Infarction, Acute (AMI)/ST Elevation Myocardial Infarction (STEMI)

Myocardial Infarction, Acute (AMI)/ST Elevation Myocardial Infarction (STEMI)

Description

Emergency Treatment

Referral


ICD 10 code: I21.0-3/I21.9/I22.0-1/I22.8-9/I24.8-9/I25.6/I25.8-9

DESCRIPTION

AMI/STEMI is caused by the complete or partial occlusion of a coronary artery and requires prompt hospitalisation and intensive care management.

The major clinical feature is severe chest pain with the following characteristics:

  • Site: retrosternal or epigastric
  • Quality: crushing, constricting or burning pain or discomfort
  • Radiation: to the neck and/or down the inner part of the left arm
  • Duration: at least 20 minutes and often not responding to sublingual nitrates
  • Occurrence: at rest

May be associated with:

  • Pallor 
  • Pulmonary oedema
  • Sweating 
  • A decrease in blood pressure
  • Arrhythmias

Note
Not all features have to be present


EMERGENCY TREATMENT

Before transfer

Cardio-pulmonary resuscitation if necessary (See: Cardiac arrest – cardiopulmonary resuscitation)

  • Oxygen 40% via facemask, if saturation < 94% or if in distress

CAUTION

Do not administer oxygen to acutely ill patients who are not hypoxic (SPO2 ≥ 96%)


LoE:IIb25

AND

  • Aspirin, oral, 150 mg as a single dose (chewed or dissolved) as soon as possible

LoE:Ia26

AND

  • Nitrates, short acting, e.g.:
  • Isosorbide dinitrate, sublingual, 5 mg, immediately as a single dose
    • May be repeated at 5-minute intervals for 3 or 4 doses

LoE:IVb27

AND

  • Morphine 10 mg diluted with 10 mL of water for injection or sodium chloride 0.9%, slow IV (Doctor prescribed)
    • Start with 5 mg; thereafter slowly increase by 1 mg/minute up to 10mg
    • Can be repeated after 4–6 hours if necessary, for pain relief
    • Beware of hypotension

AND

  • Thrombolytic, e.g.: (see table for time window below): (Doctor initiated), e.g.:
  • Streptokinase, IV 1.5 million units diluted in 100 mL sodium chloride 0.9%, infused over 30–60 minutes. Do not use heparin if streptokinase is given
    • Hypotension may occur. If it does, reduce the rate of infusion but strive to complete it in < 60 minutes
    • Streptokinase is antigenic and should not be re-administered in the period of 5 days to 2 years after 1st administration
    • Severe allergic reactions are uncommon but antibodies which may render it ineffective may persist for years

LoE:IIb28

LoE:IIb29

Considerations for initiating thrombolytics

Contra-indications 

For acute myocardial infarction
with ST elevation or left bundle branch block:

- Maximal chest pain is ≤6 hours doctor to initiate treatment

- If beyond 6 hours and chest pain, consult a specialist

- >6 hours and no chest pain, thrombolytic not indicated. Manage as above and refer patient.

LoE:Ia30
 
Absolute:
- Streptokinase used within the last year
- Previous allergy
- CVA within the last 3 months
- History of recent major trauma
- Bleeding within the last month
- Aneurysms
- Brain or spinal surgery or head injury within the preceding month, or recent (<3 weeks) major surgery,
- Active bleeding or known bleeding disorder
- Aortic dissection
 
Relative (consult specialist):
- Refractory hypertension
- Warfarin therapy
- Recent retinal laser treatment
- Subclavian central venous catheter
- Pregnancy
- TIA in the preceding 6 months
-Traumatic resuscitation

Table 4.2: Streptokinase therapy


Note: 

Refer all suspected or diagnosed cases urgently


Continuation of aftercare treatment initiated at higher level of care:

Continue therapy with appropriate lifestyle modification and adherence support

  • Aspirin, oral, 150 mg daily (continued indefinitely in absence of contraindications)

LoE:Ia31

When clinically stable without signs of heart failure, hypotension, bradydysrhythmias or asthma:

  • Cardio-selective beta-blocker, e.g.: (Doctor prescribed)
  • Atenolol, oral, 50 mg daily

AND

  • HMGCoA reductase inhibitors (statins), e.g.:
  • Rosuvastatin, oral, 10 mg at night

LoE:Ia32

Patients on protease inhibitor:

  • Atorvastatin, oral, 10 mg at night

LoE:Ia33

Patients on amlodipine (and not on a protease inhibitor):

  • Simvastatin, oral, 10-20 mg at night

LoE:Ia34

If patient complains of muscle pain:

Reduce dose e.g.:

  • If simvastatin 20 mg not tolerated, reduce to 10 mg

LoE:Ia35

OR

  • Refer for further management

AND

If there is cardiac failure or LV dysfunction (Doctor initiated):

  • ACE-inhibitor, e.g.:
  • Enalapril, oral, target dose 10 mg 12 hourly (usually titrated from 2.5 mg 12 hourly)

LoE:Ia36

Angioedema is a potentially serious complication of ACE-inhibitor treatment and if it occurs it is a contraindication to continued therapy or to re-challenge.

REFERRAL

Urgent

  • All suspected or diagnosed cases

Click here for the pdf.


Standard Treatment Guidelines and Essential Medicines List for South Africa, Primary Healthcare, 2020-2024_Version 1.0_1 November 2024

Chapter 4: Cardiovascular Conditions_4.4 Myocardial Infarction, Acute (AMI)/ST Elevation Myocardial Infarction (STEMI)

Drugs mentioned

ICD-10 codes

NeoHealth® ID 20214 · updated 6/18/2025